Skip to main content

Peer Review reports

From: Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial

Original Submission
19 Jan 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 Feb 2024 Reviewed Reviewer Report
25 Feb 2024 Reviewed Reviewer Report
6 Mar 2024 Author responded Author comments - Ahmad Zolghadriha
Resubmission - Version 3
6 Mar 2024 Submitted Manuscript version 3
7 Mar 2024 Author responded Author comments - Ahmad Zolghadriha
Resubmission - Version 4
7 Mar 2024 Submitted Manuscript version 4
23 Mar 2024 Reviewed Reviewer Report
24 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
25 Mar 2024 Editorially accepted
7 May 2024 Article published 10.1186/s12888-024-05716-0

You can find further information about peer review here.

Back to article page